Bml Capital Management, LLC Ikena Oncology, Inc. Transaction History
Bml Capital Management, LLC
- $132 Billion
- Q2 2025
A detailed history of Bml Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 4,030,102 shares of IKNA stock, worth $5.56 Million. This represents 4.09% of its overall portfolio holdings.
Number of Shares
4,030,102
Previous 3,710,803
8.6%
Holding current value
$5.56 Million
Previous $4.75 Billion
13.7%
% of portfolio
4.09%
Previous 3.84%
Shares
5 transactions
Others Institutions Holding IKNA
# of Institutions
43Shares Held
33.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.93 Million1.48% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.65 Million2.97% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.53 Million0.23% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.88 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.52MShares$3.47 Million0.11% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $50M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...